See analyst estimates and all valuation multiples for Pharmacies
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $173B | 0.4x | 10.3x | |
| $26.0B | 7.1x | 29.7x | |
| $23.9B | n/a | n/a | |
| $14.9B | 1.5x | 23.9x | |
| $11.8B | 0.3x | 5.0x | |
| $10.0B | 0.8x | 16.4x | |
| $9.9B | 1.2x | 14.0x | |
| $9.7B | 2.0x | 31.1x | |
| $7.8B | 0.9x | 14.2x | |
| $5.9B | 0.8x | 8.7x | |
| $4.6B | 1.5x | 10.9x | |
| $4.0B | 0.6x | 9.2x | |
| $4.0B | 0.5x | 9.7x | |
| $3.8B | 1.1x | 9.0x | |
| $3.8B | 1.4x | 8.3x | |
| $3.7B | 0.2x | 5.4x | |
| $3.5B | 0.5x | 8.5x | |
| $3.1B | 0.8x | 7.0x | |
| $3.0B | 0.6x | 7.3x | |
| $2.9B | 0.9x | 11.9x | |
| $2.8B | 0.4x | 4.7x | |
| $2.2B | 0.9x | 10.7x | |
| $2.1B | 0.6x | 6.5x | |
| $1.8B | 1.6x | 12.8x | |
| $1.7B | 0.9x | 7.1x | |
| $1.6B | 0.5x | 9.2x | |
| $1.6B | 0.4x | 20.8x | |
| $1.6B | 0.4x | 20.8x | |
| $1.5B | n/a | n/a | |
| $1.5B | 0.4x | 5.2x | |
| $1.2B | n/a | n/a | |
| $1.2B | n/a | n/a | |
| $1.2B | 1.6x | 19.3x | |
| $1.1B | 0.4x | n/a | |
| $1.1B | 0.4x | 9.5x | |
| $1.1B | 0.3x | 8.9x | |
| $1.0B | 0.8x | 10.0x | |
| $1.0B | 1.3x | 3.7x | |
| $996M | n/a | n/a | |
| $770M | n/a | n/a | |
| $663M | 0.6x | 9.1x | |
| $650M | n/a | n/a | |
| $571M | 1.0x | n/a | |
| $430M | 0.3x | -7.2x | |
| $412M | n/a | n/a | |
| $343M | n/a | n/a | |
| $336M | n/a | n/a | |
| $294M | 0.7x | 10.1x | |
| $269M | 0.1x | n/a | |
| $163M | n/a | n/a | |
| $155M | n/a | n/a | |
| $121M | n/a | n/a | |
| $112M | n/a | n/a | |
| $85.2M | n/a | n/a | |
| $57.2M | n/a | n/a | |
| $25.4M | 0.4x | -86.8x | |
| $19.5M | n/a | n/a |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Pharmacies